Clinical Trial Update: The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing tolerability, pharmacokinetics, and pharmacodynamics of HEC110114 tablets in subjects with chronic hepatitis C; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HEC110114

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Chronic Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED